Market News Today — AI-Curated Stock & Crypto Headlines

Galderma Group AG shares slumped the most in more than a year after the Swiss dermatology firm said the US …

The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use and addiction.

Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC …

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 25, …

The FDA advisory committee recommended Moderna's flu vaccine for approval. Moderna CEO Stéphane Bancel tells Romaine Bostick and Katie Greifeld …

Bloomberg's Madison Muller and Amanda Mull break down a rising black-market trend in the 'wellness' space, as customers look for …

On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing …

This summer the FDA will consider loosening restrictions on certain peptide injections, with encouragement from RFK Jr. and the Trump …

The announcement comes months after UniQure became embroiled in a public debate with FDA leaders over the clinical trial data …

UniQure NV shares soared after the company announced it will be able to seek US approval for its Huntington’s disease …

Replimune was among the drugmakers that had criticized the FDA for what they called inconsistent guidance around trials and approvals.

The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former …